Favorites Sign in

One plan - full access

No subscription, no auto-renewal, no hidden terms.
Pay once and use it for 30 days.

PRO plan No auto-renewal
$18

30 days of full access
One-time payment

🌐 US & Global Companies
Get access for 30 days →
♧ Secure payment · Instant access

What is included

  • ✓Full access to detailed company analysis
  • ✓Fundamental screener
  • ✓Advanced stock screener filters
  • ✓5 ratings. Separate lists for US & Global Companies and MOEX
  • ✓Company data export in XLSX and CSV
  • ✓MarketCap’s overall ranking of top companies
  • ✓Analytics updates after each new financial report
⚠ The service is not an investment advisor. Financial statement data from public companies is available to everyone - MarketCap structures and analyzes it.
  1. Home
  2. Companies
  3. Molina Healthcare
  4. Financial Ratios
Molina Healthcare logo
Molina Healthcare MOH
$ 214.9 -2.26%
report update icon

Quarterly report 2026-Q2
added 07-23-2026

Molina Healthcare Financial Ratios 2025-2008 | MOH

Brief overview of Molina Healthcare's valuation and returns

The review covers five available annual periods spanning 2021 to 2025.

The latest available valuation ratios are P/E 14.15x (median 20.77x), EV/EBITDA 20.44x (median 9.72x), P/S 0.15x (median 0.54x). Multiples are on average 31.9% below their own medians. Shares look cheaper than their recent historical valuation.

Current earnings relative to valuation equal about 7.1% on the 1/P/E measure. This is a valuation reference, not an expected payout.

End-period return metrics are ROE 11.6%, ROA 3%, ROCE 19.2%. Fundamental efficiency is balanced: profitability supports valuation but does not remove the need for future growth.

Price, earnings and growth produce a PEG of 5.6x. A high value reduces the cushion if growth slows.

The cash cycle changed only slightly and ended at 27.4 days.

Overall picture

Molina Healthcare's fundamental efficiency looks stronger than its current valuation relative to history. Future reports should confirm the conclusion.

Annual Financial Ratios Molina Healthcare

2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008

P/E

 14.1 13.3 20.8 21.9 27.9 18.6 10.7 11.8 -10.7 61.3 21.5 40.7 31.4 135.2 66.0 13.6 20.2 -

P/S

 0.1 0.4 0.7 0.5 0.7 0.6 0.5 0.4 0.3 0.2 0.2 0.3 0.3 0.2 0.3 0.2 0.2 -

EPS

 8.9 20.5 18.9 13.7 11.4 11.4 11.8 11.6 -9.1 0.9 2.8 1.3 1.2 0.2 0.5 1.3 0.8 -

EV (Enterprise Value)

 13.9 B 22.2 B 28.5 B 22.7 B 23.5 B 15.8 B 10.2 B 11 B 9.41 B 6.17 B 5.76 B 4.46 B 2.84 B 1.68 B 1.78 B 1.08 B 154 M -387 M

EBITDA per Share

 18.5 33 30.2 23.3 19.9 19.8 16.2 18.8 3.6 7.14 8.45 5.59 4.43 2.03 4.27 4.03 2.32 -

EV/EBITDA

 14.3 11.7 16.3 16.8 20.4 9.7 6.6 5.8 19.7 4.5 4.6 6.1 6.6 8.4 5.7 6.5 1.7 -

PEG

 5.6 0.85 1.87 0.24 0.37 0.26 2.51 0.05 0.0 -0.65 0.21 5.17 0.07 -2.52 -1.0 - - -

P/B

 1.6 3.5 5.4 5.9 7.0 6.0 4.0 5.0 4.1 1.9 2.0 2.5 1.9 1.7 1.8 1.0 - -

P/CF

 -12.5 24.4 13.6 22.5 8.7 6.6 21.2 -24.2 7.6 6.4 3.1 2.7 18.1 4.9 8.3 4.6 4.0 -

ROE %

 11.60 26.22 25.88 26.72 25.06 32.11 37.60 42.93 -38.29 3.15 9.18 6.16 5.93 1.25 2.76 7.64 5.69 -

ROA %

 3.03 7.54 7.33 6.43 5.40 7.06 10.86 9.88 -6.04 0.70 2.17 1.39 1.76 0.51 1.26 3.64 - -

ROCE %

 19.19 37.97 37.32 39.57 38.78 51.43 26.09 36.69 2.71 9.31 13.40 8.03 7.59 2.74 13.78 14.60 9.57 -

Current Ratio

 1.4 1.4 1.4 1.3 1.3 1.3 1.8 1.5 1.4 1.3 1.4 1.5 1.6 1.6 1.7 1.9 - -

DSO

 27.4 28.7 29.0 25.6 25.3 28.9 30.7 25.9 17.0 20.8 15.7 22.5 18.4 9.1 13.7 7.5 - -

DPO

 - - - - - - 11.5 8.8 7.4 8.8 10.5 10.2 20.4 12.4 50.1 - - -

Operating Cycle

 27.4 28.8 29.0 25.6 25.3 28.9 30.7 25.9 17.0 20.8 15.7 22.5 18.4 9.1 13.7 7.5 - -

Cash Conversion Cycle

 27.4 28.8 29.0 25.6 25.3 28.9 19.2 17.1 9.6 12.0 5.2 12.3 -2.0 -3.4 -36.4 7.5 - -

All numbers in USD currency

Quarterly Financial Ratios Molina Healthcare

2026-Q2 2026-Q1 2025-Q4 2025-Q3 2025-Q2 2025-Q1 2024-Q4 2024-Q3 2024-Q2 2024-Q1 2023-Q4 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1

EPS

 1.19 0.27 - 1.51 4.75 5.47 - 5.67 5.18 5.21 - 4.24 5.37 5.58 - 4 4.29 4.45 - 2.49 3.2 3.95 - 3.14 4.72 2.95 2.7 2.81 3.15 3.19 3.24 3.22 3.29 1.79 -4.59 -1.7 -4.1 1.38 -0.85 0.77 0.58 0.44 0.54 0.84 0.78 0.58 0.7 0.34 0.17 0.1 -0.2 0.17 0.54 0.65 0.55 0.07 -0.8 0.39 -0.72 0.41 0.38 0.38

EBITDA per Share

 4.38 2.4 - 3.47 8.04 8.81 - 8.92 8.26 8.13 - 6.94 8.41 8.68 - 6.6 7.01 7.1 - 5.48 5.27 6.38 - 6.01 7.94 4.88 - 5.23 5.02 4.91 - 6.51 6.78 4.33 - 1.03 -3.41 2.34 -0.11 4.52 3.53 2.42 1.36 3.75 3.56 2.35 1.94 2.97 2.11 1.24 - 1.07 1.51 1.95 1.16 0.49 -0.64 1.13 -0.35 1.12 1.04 1.08

ROE %

 9.21 14.68 14.34 21.17 25.50 26.66 19.75 26.06 27.76 31.31 24.61 32.18 34.62 35.32 25.56 31.24 31.48 33.26 24.02 32.85 40.34 41.02 30.49 39.06 39.16 35.99 37.60 41.23 44.27 46.53 42.93 11.13 -8.09 -37.56 -38.29 -21.55 -11.75 7.46 3.15 7.93 8.34 8.84 9.18 10.62 9.25 7.54 6.14 1.75 1.01 2.97 5.93 10.23 9.81 2.29 1.25 -6.39 -4.31 2.77 2.76 2.51 2.31 2.30

ROA %

 2.54 3.98 3.90 5.96 7.44 7.81 5.99 7.64 7.83 8.25 6.31 8.11 8.55 7.58 5.18 6.94 5.14 7.43 5.34 7.29 8.88 9.00 6.70 9.18 9.82 9.81 10.86 11.19 11.37 11.30 9.88 3.98 0.08 -5.46 -6.04 -3.58 -1.87 1.28 0.70 1.79 1.92 2.07 2.17 2.48 2.14 1.73 1.39 0.32 0.21 0.85 1.76 3.39 3.31 0.57 0.51 -2.81 -1.84 1.14 1.26 1.15 1.06 1.05

ROCE %

 16.88 23.45 21.42 31.21 36.90 38.28 28.23 37.49 39.93 44.81 35.33 46.34 49.84 50.92 37.09 45.86 46.37 49.09 35.78 49.56 61.02 62.57 47.09 60.20 59.93 53.99 40.92 58.83 66.48 66.44 52.16 46.10 6.72 -7.91 -21.39 -21.76 -8.54 19.29 18.56 23.80 23.90 24.99 24.86 29.58 26.28 22.00 19.10 12.29 13.54 17.97 15.59 22.51 20.02 8.50 5.18 -3.88 0.27 10.74 10.62 4.45 4.16 4.15

Current Ratio

 1.4 1.3 1.4 1.4 1.4 1.4 1.4 1.4 1.5 1.4 1.4 1.4 1.4 1.3 1.3 1.3 - 1.3 1.3 1.3 1.3 1.3 1.3 1.3 1.3 1.3 1.4 1.4 1.4 1.4 1.3 1.3 1.3 1.3 1.2 1.2 1.2 1.2 1.3 1.3 1.3 1.3 1.3 1.3 1.3 1.3 1.3 1.3 1.3 1.3 1.4 1.4 1.4 1.4 1.7 1.7 1.7 1.7 1.8 1.8 1.8 1.8

DSO

 29.0 29.4 - 29.3 29.4 27.8 - 28.6 30.4 29.6 - 25.9 27.0 27.1 - 12.8 12.2 25.4 - 24.4 24.4 24.1 - 30.4 33.0 30.9 30.0 30.2 30.6 30.3 26.0 25.8 24.9 21.6 16.1 15.8 15.9 17.2 19.6 19.6 20.4 16.5 - 15.1 15.4 17.2 - 21.9 23.5 19.7 - 16.2 17.0 12.9 - 8.9 9.2 10.6 - 13.0 13.1 -

Operating Cycle

 - 29.4 - 29.3 29.4 27.8 - 28.6 30.4 29.6 - 25.9 27.0 27.1 - 12.8 12.2 25.4 - 24.4 24.4 24.1 - 30.4 33.0 30.9 30.0 30.2 30.6 30.3 26.0 25.8 24.9 21.6 16.1 15.8 15.9 17.2 19.6 19.6 20.4 16.5 - 15.1 15.4 17.2 - 21.9 23.5 19.7 - 16.2 17.0 12.9 - 8.9 9.2 10.6 - 13.0 13.1 -

Cash Conversion Cycle

 - 29.4 - 29.3 29.4 27.8 - 28.6 30.4 29.6 - 25.9 27.0 27.1 - 12.8 12.2 25.4 - 24.4 24.4 24.1 - 30.4 33.0 30.9 30.0 30.2 30.6 30.3 26.0 25.8 24.9 21.6 16.1 15.8 15.9 17.2 19.6 19.6 20.4 16.5 - 15.1 15.4 17.2 - 21.9 23.5 19.7 - 16.2 17.0 12.9 - 8.9 9.2 10.6 - 13.0 13.1 -

All numbers in USD currency

Multiples are an important financial analysis tool for the company Molina Healthcare, allowing investors and analysts to quickly assess the company’s value and investment attractiveness based on the ratio of market indicators to the company’s financial performance. Essentially, multiples express how the market values the company relative to its earnings, revenue, equity, or other key metrics.

Advantages of Using Financial Ratios
  • Simplified Data Analysis
    Financial ratios transform large volumes of accounting data into compact and easily interpretable indicators, significantly simplifying the assessment of the company’s condition.
  • Comparability Between Companies
    Multiples standardize financial metrics, enabling objective comparison of companies of different sizes, industries, and market capitalizations.
  • Identification of Trends and Issues
    Regular analysis of ratios helps track the dynamics of financial health, identify strengths and weaknesses of the business, as well as potential risks.
  • Decision Support
    Financial multiples serve as an important tool for investors, creditors, and company management in making investment, credit, and managerial decisions.
  • Accelerated Assessment of Investment Attractiveness
    Ratios allow quick determination of key performance, liquidity, and financial stability indicators, facilitating prompt evaluation of companies’ attractiveness for investments.

Using multiples enables comparison between companies, even if they differ in size or industry, as they standardize financial data into ratios convenient for analysis. This is especially useful for evaluating companies where direct analysis of financial statements may be complex or require in-depth knowledge.

Financial Ratios of other stocks in the Health care industry

Issuer Price % 24h Market Cap Country
Centene Corporation Centene Corporation
CNC
 		$ 70.24 -0.83 % $ 34.6 B usaUSA
UnitedHealth Group Inc. UnitedHealth Group Inc.
UNH
 		$ 417.0 -0.54 % $ 379 B usaUSA
Humana Humana
HUM
 		$ 425.42 -0.46 % $ 51.2 B usaUSA
NovoCure Limited NovoCure Limited
NVCR
 		$ 15.59 -0.76 % $ 1.74 B jerseyJersey
Triple-S Management Corporation Triple-S Management Corporation
GTS
 		- 0.28 % $ 847 M usaUSA
Cigna Corporation Cigna Corporation
CI
 		$ 304.37 -0.82 % $ 80.2 B usaUSA
CVS Health Corporation CVS Health Corporation
CVS
 		$ 93.45 -1.34 % $ 118 B usaUSA
Magellan Health, Inc. Magellan Health, Inc.
MGLN
 		- -0.19 % $ 2.49 B usaUSA
Anthem Anthem
ANTM
 		- -2.32 % $ 107 B usaUSA